← Back to Search

Ultrasound + Elastography for Pediatric Pancreatitis

N/A

Recruiting

Led By David Vitale, MD

Research Sponsored by David Vitale MD

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

≤ 21 years of age, male and female

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months (3 months prior to endoscopic ultrasound through 3 months post-endoscopic ultrasound)

Awards & highlights

No Placebo-Only Group

Summary

This trial is researching pancreatic diseases in children & using ultrasound & elastography to measure fibrosis & diagnose these diseases.

Who is the study for?

This trial is for children up to 21 years old with confirmed acute recurrent or chronic pancreatitis. It includes those undergoing endoscopic ultrasound (EUS) for their care, and specifically some who are having pancreatic surgery.

What is being tested?

The study tests how well transabdominal and endoscopic ultrasound elastography can measure scarring in the pancreas of pediatric patients. This could improve diagnosis and management of childhood pancreatitis.

What are the potential side effects?

Since this trial involves diagnostic procedures rather than medications, side effects may include discomfort during the ultrasound procedure or potential risks associated with EUS.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 21 years old or younger.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months (3 months prior to endoscopic ultrasound through 3 months post-endoscopic ultrasound)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months (3 months prior to endoscopic ultrasound through 3 months post-endoscopic ultrasound)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months (3 months prior to endoscopic ultrasound through 3 months post-endoscopic ultrasound) for reporting.